Clinical Trial Update: Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update describes a vaccine therapy for HER2-negative breast cancer across Stage III to IV; the study is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: University of Washington | Conditions: HER2 Negative Breast Carcinoma, Recurrent Breast Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING